Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Rocket Pharmaceuticals, Inc. (RCKT) had Debt to Equity Ratio of 0.08 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-223.12M |
|
-- |
|
-- |
|
$231.75M |
|
$-231.75M |
|
$8.62M |
|
$-223.12M |
|
$-223.12M |
|
$-223.12M |
|
$-223.12M |
|
$-223.12M |
|
$-223.12M |
|
$-231.75M |
|
$-220.46M |
|
111.12M |
|
111.12M |
|
$-2.01 |
|
$-2.01 |
|
| Balance Sheet Financials | |
$192.73M |
|
$28.17M |
|
$137.72M |
|
$330.45M |
|
$30.21M |
|
$19.36M |
|
$23.02M |
|
$53.23M |
|
$277.22M |
|
$212.92M |
|
$277.22M |
|
108.32M |
|
| Cash Flow Statement Financials | |
$-190.01M |
|
$103.77M |
|
$0.15M |
|
$165.00M |
|
$78.90M |
|
$-86.10M |
|
$37.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.38 |
|
-- |
|
-- |
|
0.07 |
|
|
Debt to Equity Ratio |
0.08 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-190.45M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-80.49% |
|
-104.79% |
|
-67.52% |
|
-75.23% |
|
$2.56 |
|
$-1.71 |
|
$-1.71 |
|